Cenix will use its Definiens XD image analysis system to develop and optimize RNAi-based high-content screening assays to validate targets for Sygnis

Cenix BioScience GmbH

Germany / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sygnis Pharma AG

Germany / Tools, Services, and Manufacturing

$44.4m on 11/18/2011 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced